The antimicrobial stewardship program must rest on a written policy, give prescribers the current Australian therapeutic guidelines and encourage their use, run a formulary built on those guidelines with restrictions and approvals, embed the elements of the national stewardship clinical care standard, and act on use and appropriateness audits. It must review prescribing and use, draw on resistance and usage surveillance to guide prescribing, evaluate itself and act to improve appropriateness, and report to clinicians and the board on policy compliance, resistance hotspots, appropriateness actions and performance over time.
The graph holds this control, the 0 it maps to, and the evidence behind each claim, over MCP and REST.